EDGAR Filing Documents for 0001564590-15-008433

Form 8-K - Current report:

SEC Accession No. 0001564590-15-008433

Filing Date

2015-10-16

Accepted

2015-10-16 16:06:11

Documents

Period of Report

2015-10-12

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	atra-8k_20151012.htm	8-K	57478
2	EX-10.1 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT BY AND BETWEEN ATARA	atra-ex101_6.htm	EX-10.1	99554
3	EX-10.2 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT ATARA BIOTHERAPEUTIC	atra-ex102_7.htm	EX-10.2	87530
4	EX-10.3 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT ATARA BIOTHERAPEUTIC	atra-ex103_8.htm	EX-10.3	87849
5	AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT ATARA BIOTHERAPEUTICS, INC.	atra-ex104_9.htm	EX-10.4	84883
	Complete submission text file	0001564590-15-008433.txt		418568

Mailing Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080

Business Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-278-8930

Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)